Top news of the week: 27.12.2022.
Gene therapy trial shows promise for treating ‘bubble boy’ syndrome. Now comes the hard part
As gene therapies for rare diseases find success, more cracks are appearing in the current regulatory and commercialization models.
$20 Million Funding For AI-Driven Microbiome-Based Therapeutics
Biomica plans to use the $20 million in new funding from Shanghai Healthcare Capital to further develop its pipeline of microbiome-based therapeutics.
C16 Biosciences Has Built A Palm Oil Farm In Midtown Manhattan To Stop Global Deforestation
What's the biggest threat to rainforests? Palm oil. It's found in everything from shampoo to baby formula. NYC-based startup C16 Biosciences is working to replace this ubiquitous ingredient ...
Tales From the 2022 Biotech VC Fundraising Trail
After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted
STAT@JPM: What’s Next For Biotech?
Join STAT reporters and industry experts in San Francisco as they tackle the most important news emerging from JPM
Merck builds out cancer drug pipeline with Kelun-Biotech deal
The pharma will pay the Chinese drugmaker $175 million for access to seven preclinical antibody-drug conjugates, deepening ties established this year.
Lithuania Focused on Building a World-Leading Life Science Sector
Lithuania’s life science sector is fastest growing in the European Union.
Absci Pursues Google-Sized Ambitions in Drug Discovery, Manufacturing
Absci has begun building its own pipeline, as the company aims to become the Google of protein-based drug discovery and biomanufacturing.